ARMATA PHARMACEUTICALS, INC. Operating Expenses
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Operating Expenses of $12.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-06-30 was $12.82M, a 42.26% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-03-31 was $9.57M, a 10.27% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-12-31 was $14.91M, a 26.62% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-09-30 was $8.94M, a 29.81% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. operating expenses for fiscal 2025 was $41.54M, a 12.75% decline from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. operating expenses for fiscal 2024 was $47.61M, a 4.82% increase from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $45.42M, a 6.98% increase from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $42.45M, a 50.04% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.82M 10-Q · filed 2026-08-12 | $22.40M 10-Q · filed 2026-08-12 | $37.30M derived: sum of 3 quarters · filed 2026-08-12 | $46.24M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $9.57M 10-Q · filed 2026-05-13 | $24.48M derived: sum of 2 quarters · filed 2026-05-13 | $33.42M derived: sum of 3 quarters · filed 2026-05-13 | $42.43M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $14.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $23.84M derived: sum of 2 quarters · filed 2026-03-25 | $32.86M derived: sum of 3 quarters · filed 2026-08-12 | $41.54M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $8.94M 10-Q · filed 2025-11-12 | $17.95M derived: sum of 2 quarters · filed 2026-08-12 | $26.63M 10-Q · filed 2025-11-12 | $38.40M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $9.01M 10-Q · filed 2026-08-12 | $17.70M 10-Q · filed 2026-08-12 | $29.47M derived: sum of 3 quarters · filed 2026-08-12 | $42.20M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $8.68M 10-Q · filed 2026-05-13 | $20.46M derived: sum of 2 quarters · filed 2026-05-13 | $33.19M derived: sum of 3 quarters · filed 2026-05-13 | $45.10M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $11.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $24.50M derived: sum of 2 quarters · filed 2026-03-25 | $36.42M derived: sum of 3 quarters · filed 2026-03-25 | $47.61M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $12.73M 10-Q · filed 2025-11-12 | $24.64M derived: sum of 2 quarters · filed 2025-11-12 | $35.84M 10-Q · filed 2025-11-12 | $46.94M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $11.91M 10-Q · filed 2025-08-12 | $23.11M 10-Q · filed 2025-08-12 | $34.22M derived: sum of 3 quarters · filed 2025-08-12 | $45.78M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $11.19M 10-Q · filed 2025-05-14 | $22.30M derived: sum of 2 quarters · filed 2025-05-14 | $33.86M derived: sum of 3 quarters · filed 2025-05-14 | $44.47M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $22.67M derived: sum of 2 quarters · filed 2025-03-21 | $33.28M derived: sum of 3 quarters · filed 2025-03-21 | $45.42M 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | $11.56M 10-Q · filed 2024-11-13 | $22.17M derived: sum of 2 quarters · filed 2024-11-13 | $34.31M 10-Q · filed 2024-11-13 | $45.69M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $10.61M 10-Q · filed 2024-08-13 | $22.75M 10-Q · filed 2024-08-13 | $34.13M derived: sum of 3 quarters · filed 2024-08-13 | $44.09M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $12.14M 10-Q · filed 2024-05-07 | $23.52M derived: sum of 2 quarters · filed 2024-05-07 | $33.48M derived: sum of 3 quarters · filed 2024-05-07 | $44.59M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $21.34M derived: sum of 2 quarters · filed 2024-03-21 | $32.44M derived: sum of 3 quarters · filed 2024-03-21 | $42.45M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $9.96M 10-Q · filed 2023-11-14 | $21.06M derived: sum of 2 quarters · filed 2023-11-14 | $31.07M 10-Q · filed 2023-11-14 | $38.11M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $11.10M 10-Q · filed 2023-08-14 | $21.11M 10-Q · filed 2023-08-14 | $28.15M derived: sum of 3 quarters · filed 2023-08-14 | $35.55M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $10.01M 10-Q · filed 2023-05-11 | $17.05M derived: sum of 2 quarters · filed 2023-05-11 | $24.44M derived: sum of 3 quarters · filed 2023-05-11 | $31.81M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $7.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $14.43M derived: sum of 2 quarters · filed 2023-03-16 | $21.80M derived: sum of 3 quarters · filed 2023-03-16 | $28.30M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $7.39M 10-Q · filed 2022-11-09 | $14.76M derived: sum of 2 quarters · filed 2022-11-09 | $21.26M 10-Q · filed 2022-11-09 | $28.22M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $7.36M 10-Q · filed 2022-08-11 | $13.87M 10-Q · filed 2022-08-11 | $20.82M derived: sum of 3 quarters · filed 2022-08-11 | $26.73M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $6.50M 10-Q · filed 2022-05-12 | $13.46M derived: sum of 2 quarters · filed 2022-05-12 | $19.37M derived: sum of 3 quarters · filed 2022-05-12 | $23.99M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $12.87M derived: sum of 2 quarters · filed 2022-03-17 | $17.49M derived: sum of 3 quarters · filed 2022-03-17 | $22.41M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $5.91M 10-Q · filed 2021-11-10 | $10.53M derived: sum of 2 quarters · filed 2021-11-10 | $15.45M 10-Q · filed 2021-11-10 | $19.83M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $4.62M 10-Q · filed 2021-08-12 | $9.54M 10-Q · filed 2021-08-12 | $13.92M derived: sum of 3 quarters · filed 2021-08-12 | $20.70M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $4.92M 10-Q · filed 2021-05-13 | $9.30M derived: sum of 2 quarters · filed 2021-05-13 | $16.07M derived: sum of 3 quarters · filed 2021-05-13 | $21.23M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $11.15M derived: sum of 2 quarters · filed 2021-03-18 | $16.31M derived: sum of 3 quarters · filed 2021-03-18 | $19.75M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $6.78M 10-Q · filed 2020-11-12 | $11.94M derived: sum of 2 quarters · filed 2020-11-12 | $15.38M 10-Q · filed 2020-11-12 | $18.34M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $5.16M 10-Q · filed 2019-08-14 | $8.60M 10-Q · filed 2019-08-14 | $11.56M derived: sum of 3 quarters · filed 2020-03-19 | $13.99M derived: sum of 4 quarters · filed 2020-03-19 | ||||
| 2019-03-31 | $3.61M 10-Q · filed 2019-05-06 | $6.40M derived: sum of 2 quarters · filed 2020-03-19 | $8.83M derived: sum of 3 quarters · filed 2020-03-19 | $11.67M derived: sum of 4 quarters · filed 2020-03-19 | ||||
| 2018-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $5.22M derived: sum of 2 quarters · filed 2020-03-19 | $8.07M derived: sum of 3 quarters · filed 2020-03-19 | $17.66M 10-K · filed 2020-03-19 | $12.52M 10-K · filed 2019-03-25 | |||
| 2018-09-30 | $2.43M 10-Q · filed 2019-11-12 | $1.64M 10-Q · filed 2018-11-08 | $5.27M derived: sum of 2 quarters · filed 2019-11-12 | $14.86M 10-Q · filed 2019-11-12 | $7.74M 10-Q · filed 2018-11-08 | $10.71M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $2.84M 10-Q · filed 2019-08-14 | $3.05M 10-Q · filed 2018-08-09 | $12.44M 10-Q · filed 2019-08-14 | $6.11M 10-Q · filed 2018-08-09 | $8.28M derived: sum of 3 quarters · filed 2019-08-14 | $9.07M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $3.06M 10-Q · filed 2019-05-06 | $5.44M derived: sum of 2 quarters · filed 2019-05-06 | $6.22M derived: sum of 3 quarters · filed 2019-05-06 | $15.94M derived: sum of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $3.17M derived: sum of 2 quarters · filed 2019-03-25 | $12.88M derived: sum of 3 quarters · filed 2019-03-25 | $16.27M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | $784.00K 10-Q · filed 2018-11-08 | $10.50M derived: sum of 2 quarters · filed 2018-11-08 | $13.89M 10-Q · filed 2018-11-08 | $25.77M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $9.71M 10-Q · filed 2018-08-09 | $13.10M 10-Q · filed 2018-08-09 | $24.99M derived: sum of 3 quarters · filed 2018-08-09 | $28.42M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $3.39M 10-Q · filed 2018-05-15 | $15.27M derived: sum of 2 quarters · filed 2018-05-15 | $18.71M derived: sum of 3 quarters · filed 2018-05-15 | $22.40M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $11.89M 10-K · filed 2017-03-27 | $15.32M derived: sum of 2 quarters · filed 2017-11-14 | $19.01M derived: sum of 3 quarters · filed 2017-11-14 | $23.64M 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | $3.44M 10-Q · filed 2017-11-14 | $7.13M derived: sum of 2 quarters · filed 2017-11-14 | $11.75M 10-Q · filed 2017-11-14 | $14.82M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $3.69M 10-Q · filed 2017-08-14 | $8.32M 10-Q · filed 2017-08-14 | $11.38M derived: sum of 3 quarters · filed 2017-08-14 | $13.96M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $4.62M 10-Q · filed 2017-05-15 | $7.69M derived: sum of 2 quarters · filed 2017-05-15 | $10.26M derived: sum of 3 quarters · filed 2017-05-15 | $12.96M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $3.07M 10-K · filed 2017-03-27 | $5.64M derived: sum of 2 quarters · filed 2017-03-27 | $8.33M derived: sum of 3 quarters · filed 2017-03-27 | $10.70M 10-K · filed 2017-03-27 | ||||
| 2015-09-30 | $2.57M 10-K · filed 2017-03-27 | $5.26M derived: sum of 2 quarters · filed 2017-03-27 | $7.63M 10-Q · filed 2016-11-10 | $10.33M derived: sum of 4 quarters · filed 2017-03-27 | ||||
| 2015-06-30 | $2.69M 10-K · filed 2017-03-27 | $5.06M 10-Q · filed 2016-08-15 | $7.76M derived: sum of 3 quarters · filed 2017-03-27 | $13.10M derived: sum of 4 quarters · filed 2017-03-27 | ||||
| 2015-03-31 | $2.37M 10-K · filed 2017-03-27 | $5.07M derived: sum of 2 quarters · filed 2017-03-27 | $10.40M derived: sum of 3 quarters · filed 2017-03-27 | $14.25M derived: sum of 4 quarters · filed 2017-03-27 | ||||
| 2014-12-31 | $2.70M 10-K · filed 2016-03-30 | $8.03M derived: sum of 2 quarters · filed 2016-03-30 | $11.88M derived: sum of 3 quarters · filed 2016-03-30 | $14.52M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $5.33M 10-K · filed 2016-03-30 | $4.95M 10-Q · filed 2014-11-14 | $9.18M derived: sum of 2 quarters · filed 2016-03-30 | $11.82M 10-Q · filed 2015-11-16 | $11.57M 10-Q · filed 2014-11-14 | $14.15M derived: sum of 4 quarters · filed 2016-03-30 | ||
| 2014-06-30 | $3.85M 10-K · filed 2016-03-30 | $4.03M 10-Q · filed 2014-09-12 | $6.49M 10-Q · filed 2015-08-13 | $6.63M 10-Q · filed 2014-09-12 | $8.82M derived: sum of 3 quarters · filed 2016-03-30 | $11.16M derived: sum of 4 quarters · filed 2016-03-30 | ||
| 2014-03-31 | $2.64M 10-K · filed 2016-03-30 | $2.59M 10-Q · filed 2014-05-20 | $4.97M derived: sum of 2 quarters · filed 2016-03-30 | $7.31M derived: sum of 3 quarters · filed 2016-03-30 | $13.75M derived: sum of 4 quarters · filed 2016-03-30 | |||
| 2013-12-31 | $2.33M derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | $4.67M derived: sum of 2 quarters · filed 2015-04-15 | $11.11M derived: sum of 3 quarters · filed 2015-04-15 | $12.46M 10-Q/A · filed 2015-04-15 | $12.76M 10-Q · filed 2014-05-20 | |||
| 2013-09-30 | $2.34M 10-Q/A · filed 2015-04-15 | $2.32M 10-Q · filed 2014-11-14 | $8.78M derived: sum of 2 quarters · filed 2015-04-15 | $10.13M 10-Q/A · filed 2015-04-15 | $10.15M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $6.44M 10-Q/A · filed 2015-04-15 | $6.60M 10-Q · filed 2014-09-12 | $7.79M 10-Q/A · filed 2015-04-15 | $7.84M 10-Q · filed 2014-09-12 | ||||
| 2013-03-31 | $1.35M 10-Q/A · filed 2015-04-15 | $1.24M 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |